Six Sigma was born in an era where most defects were tangible: contamination events, yield loss, rework, scrap, downtime, or out-of-spec results. In pharma and medical devices, those issues still matter. But digital transformation has changed the game by moving a significant portion of “defect creation” upstream into information flows—how data is captured, reviewed, approved, transferred, and interpreted across validated systems.

Today, the fastest way to damage cycle time, compliance, and patient safety isn’t always a machine fault. It can be a broken workflow in an eQMS, a poorly designed electronic batch record step, a master-data mismatch, or a dashboard decision based on incomplete context.

Six Sigma still works. But it now operates in a more digital, interconnected, compliance-heavy world.

Six Sigma hasn’t changed in principle—only in what it targets

At its core, Six Sigma remains a disciplined approach to reducing variation and improving process capability using structured methods like DMAIC (Define–Measure–Analyse–Improve–Control). What has changed is the definition of the “process.”

In modern pharma and med device operations, the “process” is rarely just a sequence of physical steps. It is a socio-technical system:

• People executing work
• SOPs and batch records defining it
• Digital platforms enabling it (MES, LIMS, ERP, eQMS, QMS, PLM)
• Data pipelines feeding it
• Automated rules controlling it
• Interfaces between systems creating handoffs and hidden failure points

Six Sigma now needs to treat the digital layer as part of the process—not as a separate IT problem.

The biggest shift: defects are increasingly digital

In regulated manufacturing, “defect” has expanded beyond physical nonconformance to include information defects:

Examples of digital defects in pharma & med device

• Batch record review delays caused by workflow bottlenecks or unclear exceptions
• Deviations triggered by inconsistent data capture or missing mandatory fields
• CAPA cycles extended by poor routing rules, unclear ownership, or duplicate records
• Data integrity risks from manual transcription, uncontrolled spreadsheets, or weak audit trail practices
• Complaints trending distorted by inconsistent coding or taxonomy in QMS
• Change controls stuck in queues due to system design and handoff complexity
• Supplier quality issues amplified by poor master data alignment or slow document control

Many of these problems look like “people issues,” but Six Sigma teams increasingly discover the true root cause is system design: forms, rules, permissions, interfaces, and the overall architecture of the workflow.

Measurement has moved from sampling to “always-on”—but trust matters more than ever

Digital transformation gives organisations the ability to measure continuously:

• event logs, timestamps, queues
• system-generated exceptions
• equipment telemetry
• electronic signatures and audit trails

This can make Six Sigma projects faster and more precise—if the measurement system is valid.

In a digital context, Measurement System Analysis expands into questions like:

• Are data definitions consistent across systems (ERP vs MES vs LIMS)?
• Are timestamps reliable and comparable?
• Are workflows producing the same outcome every time, or are users working around them?
• Is data complete, attributable, legible, contemporaneous, original, accurate (ALCOA+)?

In short: digital data is plentiful, but data integrity becomes the new MSA.

Root cause analysis now includes “digital root causes”

Traditional RCA often focused on:

• operator error
• equipment failures
• material variation
• environmental conditions

Those still apply. But now common root causes include:

• unnecessary handoffs between systems (and the delays/errors they create)
• poorly designed data capture fields that encourage inconsistent entries
• missing validation rules (allowing bad data to pass)
• rigid workflows that don’t match reality, forcing workarounds
• fragmented ownership: “IT owns the system, Quality owns the process, Operations owns the output”

Modern Six Sigma in pharma/med device increasingly benefits from:

• process mining to compare “work as imagined” vs “work as done”
• digital value stream mapping across QMS/MES/LIMS
• exception analysis: where review-by-exception is failing and why

Control has evolved: from policing compliance to designing compliance in

One of the most positive changes digital transformation brings to Six Sigma is how controls are implemented.

Historically, sustaining gains relied heavily on:

• training and re-training
• SOP revisions
• audits
• manual checks

Digitally enabled control means you can embed quality into the workflow:

• mandatory field completion
• range checks and logic rules
• automated sequencing (can’t skip steps)
• automated deviation triggers
• electronic signatures + enforced roles
• dashboards that show drift early
• real-time SPC alerts where appropriate

This is effectively poka-yoke at system level—and it’s one of the strongest ways to hold the “C” in DMAIC.

The trap: digitising waste (and validating it)

Pharma and med device companies sometimes digitise existing processes without simplifying them first—then validate a complex workflow that nobody likes, nobody follows cleanly, and nobody can change quickly.

That’s expensive, slow, and it can hard-code inefficiency.

Six Sigma is the antidote because it forces the hard questions before the build:

• What is the true CTQ?
• Which steps add value vs create delays?
• Where is the variation actually coming from?
• Can we remove steps before we automate them?
• What should be standardised before we validate?

A digitally transformed organisation with weak process thinking can automate problems. A Six Sigma organisation with digital tools can eliminate them—and lock in the gain.

A practical “Digital Six Sigma” example set (pharma + med device)

Here are three high-value examples that resonate across both sectors:

1) Deviation reduction without blame

Problem: deviation rates rising; investigations slow; recurring human error themes.
Digital Six Sigma view: reduce variation by fixing workflow design:

• improve data capture so deviation narratives are structured and comparable
• reduce duplicate entry across systems
• automate routing to the right SME based on category
• introduce better triage rules (minor vs major)
• use trend dashboards with consistent coding

Outcome: fewer repeat deviations, faster closure, better insight.

2) Batch release cycle time improvement (review-by-exception done properly)

Problem: QP release / QA release is delayed by review workload.
Digital Six Sigma view: treat “review” as a process with measurable flow:

• identify true exceptions vs “noise”
• standardise exception thresholds
• redesign EBR/MES steps to reduce ambiguous entries
• implement exception dashboards and clear escalation rules

Outcome: cycle time reduction without compromising compliance.

3) Supplier quality + complaints: improve signal quality

Problem: too much complaint data, weak insights, slow supplier response.
Digital Six Sigma view: improve measurement + categorisation:

• standardise taxonomy, defect codes, and severity logic
• enforce structured data capture
• automate supplier notification workflows with SLA timers
• build Pareto and trend analysis that reflects reality

Outcome: clearer top drivers, faster containment, better CAPA effectiveness.

What this means for belts and improvement leaders

In pharma and med device, the modern Six Sigma skillset is expanding. Alongside statistical thinking, teams need:

• data literacy (definitions, lineage, integrity)
• systems thinking (how MES/LIMS/QMS/ERP interact)
• change control and validation awareness (risk-based approaches)
• change management (adoption is often the real constraint)

The best improvement leaders now sit at the intersection of Quality, Operations, and Digital.

Final thought: Six Sigma is becoming the “operating logic” of digital quality

Digital transformation has not made Six Sigma less relevant in regulated industries—it has made Six Sigma more strategic.

When organisations digitise without process discipline, they often validate complexity and automate waste. When they combine digital capability with Six Sigma thinking, they can reduce variation at its source, embed compliance into design, and sustain improvements through system-level control.

That’s not the end of Six Sigma—it’s Six Sigma evolving into Digital Process Excellence for modern pharma and medical devices.